Edition:
United States

Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

0.22USD
22 Jun 2018
Change (% chg)

$-0.01 (-5.53%)
Prev Close
$0.23
Open
$0.23
Day's High
$0.25
Day's Low
$0.22
Volume
188,873
Avg. Vol
329,465
52-wk High
$1.63
52-wk Low
$0.17

Chart for

About

Biocept, Inc. is an early commercial-stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), assays utilizing a standard blood sample, or liquid biopsy. The Company's Target-Selector offering is based on an internally... (more)

Overall

Beta: 1.88
Market Cap(Mil.): $15.14
Shares Outstanding(Mil.): 68.21
Dividend: --
Yield (%): --

Financials

  BIOC.OQ Industry Sector
P/E (TTM): -- 41.65 34.14
EPS (TTM): -0.62 -- --
ROI: -187.20 14.42 13.10
ROE: -221.03 17.62 15.09

BRIEF-Biocept Inc Files For Mixed Shelf Of Up To $50 Million

* BIOCEPT INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING Source http://bit.ly/2wJv6pr Further company coverage:

May 15 2018

BRIEF-Biocept Q1 Loss Per Share $0.11

* Q1 REVENUE $800,000 VERSUS $1.7 MILLION Source text for Eikon: Further company coverage:

May 15 2018

BRIEF-Biocept Inc Obtains Patent For A Certain Technology In China

* BIOCEPT OBTAINS PATENT FOR ITS TARGET SELECTOR MOLECULAR BIOMARKER TECHNOLOGY IN CHINA Source text for Eikon: Further company coverage:

Mar 29 2018

BRIEF-Biocept Reports Q4 Loss Of $0.18 Per Share

* BIOCEPT REPORTS 2017 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

Mar 28 2018

BRIEF-Biocept And Thermo Fisher Scientific Enter Into Technology And Commercial Collaboration

* BIOCEPT AND THERMO FISHER SCIENTIFIC ENTER INTO TECHNOLOGY AND COMMERCIAL COLLABORATION

Mar 28 2018

BRIEF-Biocept Prices $15 Million Public Offering Of 33.3 Mln Shares and Warrants

* BIOCEPT ANNOUNCES PRICING OF $15.0 MILLION PUBLIC OFFERING OF 33,333,333 SHARES OF COMMON STOCK AND WARRANTS TO PURCHASE 33,333,333 SHARES OF COMMON STOCK

Jan 26 2018

BRIEF-Biocept Offers 18.8 Mln Shares Of Common Stock

* BIOCEPT INC FILES TO SAY IT OFFERING 18.8 MILLION SHARES OF ITS COMMON STOCK AND WARRANTS TO PURCHASE SHARES OF COMMON STOCK - SEC FILING

Jan 22 2018

Earnings vs. Estimates